Skip to content
Application 064032
- Type
- ANDA
- Sponsor
- HOSPIRA
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | TAZICEF | CEFTAZIDIME | INJECTABLE;INJECTION | 1GM/VIAL | No | No |
| 002 | TAZICEF | CEFTAZIDIME | INJECTABLE;INJECTION | 2GM/VIAL | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 0409-5092 | TAZICEF | CEFTAZIDIME | Hospira, Inc. | ANDA | Current |
| 0409-5092 | TAZICEF | CEFTAZIDIME | Hospira, Inc. | ANDA | Current |
| 0409-5092 | TAZICEF | CEFTAZIDIME | Hospira, Inc. | ANDA | Current |
| 0409-5092 | TAZICEF | CEFTAZIDIME | Hospira, Inc. | ANDA | Current |
| 0409-5092 | TAZICEF | CEFTAZIDIME | Hospira, Inc. | ANDA | Current |
| 0409-5092 | TAZICEF | CEFTAZIDIME | Hospira, Inc. | ANDA | Current |
| 0409-5092 | TAZICEF | CEFTAZIDIME | Hospira, Inc. | ANDA | Current |
| 0409-5092 | TAZICEF | CEFTAZIDIME | Hospira, Inc. | ANDA | Current |
| 0409-5093 | TAZICEF | CEFTAZIDIME | Hospira, Inc. | ANDA | Current |
| 0409-5093 | TAZICEF | CEFTAZIDIME | Hospira, Inc. | ANDA | Current |
| 0409-5093 | TAZICEF | CEFTAZIDIME | Hospira, Inc. | ANDA | Current |
| 0409-5093 | TAZICEF | CEFTAZIDIME | Hospira, Inc. | ANDA | Current |
| 0409-5093 | TAZICEF | CEFTAZIDIME | Hospira, Inc. | ANDA | Current |
| 0409-5093 | TAZICEF | CEFTAZIDIME | Hospira, Inc. | ANDA | Current |
| 0409-5093 | TAZICEF | CEFTAZIDIME | Hospira, Inc. | ANDA | Current |
| 0409-5093 | TAZICEF | CEFTAZIDIME | Hospira, Inc. | ANDA | Current |